Ajmani Karin 4
4 · Progyny, Inc. · Filed Oct 24, 2019
Insider Transaction Report
Form 4
Progyny, Inc.PGNY
Ajmani Karin
EVP, Chief of Strategic Dev.
Transactions
- Exercise/Conversion
Common Stock
2019-10-24$0.87/sh+64,017$55,695→ 822,058 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-10-24−64,017→ 622,386 totalExercise: $0.87Exp: 2025-09-15→ Common Stock (64,017 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2019-10-24−199,986→ 387,424 totalExercise: $0.91Exp: 2027-08-03→ Common Stock (199,986 underlying) - Exercise/Conversion
Common Stock
2019-10-24$0.91/sh+199,986$181,987→ 1,022,046 total
Footnotes (2)
- [F1]Fully Vested.
- [F2]One-fourth (1/4th) of the shares subject to the Option vested on April 1, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.